Polyethylenimine Linear (PEI, MW 40,000): High-Efficiency DNA Transfection Reagent for In Vitro Studies

Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer used as a DNA transfection reagent in mammalian cells (APExBIO, product page). PEI condenses DNA into nanoparticles that interact with cell surface proteoglycans, facilitating endocytosis-mediated uptake (Li et al. 2025). It supports high transfection efficiencies (60–80%) in diverse cell lines, with compatibility in serum-containing media. PEI MW 40,000 is validated for both small-scale and large-scale applications, including transient gene expression and recombinant protein production (see detailed mechanism). This article provides mechanistic insight, performance benchmarks, and integration strategies for molecular biology workflows.

Biological Rationale

Efficient delivery of nucleic acids into mammalian cells is essential for in vitro studies of gene function, protein production, and pathway analysis. Polyethylenimine (PEI) is a synthetic, polycationic polymer that enables DNA condensation and subsequent cellular uptake (APExBIO). The linear form of PEI (MW 40,000) is preferred due to reduced cytotoxicity and reproducible transfection efficiency compared to branched variants (compare mechanisms). PEI-based transfection is a non-viral approach, minimizing biosafety concerns. Its compatibility with serum allows for physiological culture conditions, preserving cell viability and phenotype during gene delivery. High DNA binding capacity and endosomal escape properties make PEI MW 40,000 especially suitable for transient transfection and recombinant protein expression in cell lines such as HEK-293, CHO-K1, and HeLa (see application innovations).

Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

PEI MW 40,000 acts as a DNA transfection reagent by condensing negatively charged DNA into positively charged nanoparticles. This condensation relies on electrostatic interactions between the amine groups of PEI and the phosphate backbone of DNA (APExBIO). The resulting polyplexes display a net positive charge, which facilitates binding to anionic cell surface proteoglycans and other residues. Upon attachment, the polyplexes are internalized predominantly via clathrin-mediated and caveolin-mediated endocytosis pathways. Once inside the endosome, the 'proton sponge effect' of PEI leads to osmotic swelling and rupture of the endosomal membrane, releasing the DNA into the cytosol (detailed mechanism). Translocation of DNA to the nucleus allows for transient gene expression. The linear configuration of PEI is associated with lower cytotoxicity and improved transfection reproducibility compared to branched analogs.

Evidence & Benchmarks

• PEI MW 40,000 achieves transfection efficiencies of 60-80% in HEK-293, CHO-K1, and HeLa cells under optimized conditions (serum-containing DMEM, 37°C, N/P ratio 10:1, 24–48 h post-transfection) (Li et al. 2025).
• Linear PEI shows reduced cytotoxicity relative to branched PEI, maintaining >85% cell viability at working concentrations (2–5 μg/mL PEI) (see Table 2).
• DNA-PEI polyplexes are stable for at least 30 minutes at room temperature in physiological buffers (pH 7.4) prior to transfection (protocols and troubleshooting).
• PEI-mediated transfection is compatible with serum concentrations up to 10% fetal bovine serum (FBS) without significant loss of efficiency (benchmarking study).
• PEI MW 40,000 is validated for scaling from 96-well plates to bioreactors up to 100 liters for recombinant protein production (APExBIO).

Applications, Limits & Misconceptions

Polyethylenimine Linear (PEI, MW 40,000) is applied in transient transfection protocols for the production of recombinant proteins, functional gene assays, and pathway analysis in mammalian cells. The reagent is suitable for a wide range of adherent and suspension cell lines, including HEK-293, HEK293T, CHO-K1, HepG2, and HeLa. Its robustness in the presence of serum makes it suitable for physiological experiments and high-throughput screening (K1029 kit). For neuroinflammatory research, PEI offers a non-viral alternative to lentiviral or AAV vectors, avoiding integration-related artifacts (Li et al. 2025).

Common Pitfalls or Misconceptions

• PEI MW 40,000 is not suitable for in vivo gene delivery in animal models due to rapid clearance and potential toxicity at systemic levels.
• Branched PEI should not be substituted for linear PEI without optimization, as transfection efficiencies and cytotoxicity profiles differ significantly.
• PEI-mediated transfection does not guarantee stable genomic integration; it mainly supports transient gene expression.
• DNA-PEI polyplexes must be freshly prepared; prolonged incubation (>1 hour) may reduce efficiency.
• High DNA or PEI concentrations may lead to precipitate formation and cell death; titration is essential for each cell line.

Workflow Integration & Parameters

For optimal transfection, DNA and PEI are mixed at an N/P (nitrogen/phosphate) ratio of 10:1, incubated for 15–20 minutes at room temperature before addition to the cells. The recommended working concentration is 2.5 mg/mL PEI (supplied by APExBIO in 4 mL and 8 mL vials). Transfection is typically performed in serum-containing DMEM or RPMI at 37°C, 5% CO₂. For small-scale transfection, 96-well plates are used with 0.1–0.5 μg DNA per well; for large-scale protein production, up to 100 L bioreactors are feasible. Long-term storage should be at –20°C, with frequent-use aliquots kept at 4°C to avoid repeated freeze-thaw cycles (product specifications). For advanced troubleshooting, see this guide, which complements this article by detailing protocol optimization and troubleshooting strategies.

Conclusion & Outlook

Polyethylenimine Linear (PEI, MW 40,000) remains a gold standard for DNA transfection in in vitro mammalian cell studies, balancing high efficiency, serum compatibility, and scalability. Its validated performance across cell lines and workflows ensures reproducibility and reliability in molecular biology research. Future innovations may further enhance its specificity and reduce cytotoxicity, broadening its utility in emerging cell and gene therapy models. For comprehensive mechanistic insight and translational applications, this article extends prior analyses by integrating recent benchmarks and workflow considerations (clarifies application boundaries).